So grab that cup of stimulation and get started. Our flavor today is Irish cream, for those tracking our habits. Now, though, the time has come to get busy. So please grab your own cup and dig in ...
In Bakery division, the company launched two new products, namely Chapi and Cream Rolls ... a Scheme of Amalgamation between the Company and GlaxoSmithKline Consumer Healthcare Limited (GSK ...
GlaxoSmithKline Pharmaceuticals Limited is ... Other branded generics launched during the year were Modvate 3 cream (Beclomethasone in combination with Clotrimazole and Neomycin) and Modvate ...
If the ice cream business isn’t part of the FTSE 100 ... Here are the 2025 dividend forecasts for FTSE giants Unilever, GSK, ...
GSK Consumer Healthcare officially merged with ... is also present in the food segment in areas such as tea, coffee, ice cream and frozen desserts, foods and health food drinks.
In two examples of change, the firm’s implementing “a comprehensive productivity programme” and working towards separating ...
Full Year 2024 Guidance: 7% to 9% sales growth, 11% to 13% profit growth. GSK PLC (NYSE:GSK) reported a 9% sales growth and 19% profit growth year-to-date, reflecting strong performance in ...
The Moderna lawsuits echo similar claims made by GSK when it sued Pfizer and BioNTech for allegedly infringing upon the company’s mRNA patents back in April. At the time, Pfizer voiced ...
GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...
Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...
By Blake Brittain (Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology ...
GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been shown to reduce nasal polyps in a pair of phase 3 trials. The ANCHOR ...